| | | | | | | | | Sponsored | | Support earlier, more connected cardiometabolic insight with Siemens Healthineers. Includes the first and only prognostic high-sensitivity troponin I assay available in the U.S. and the first and only blood test authorized for use as a prognostic marker in patients with advanced fibrosis due to MASH. Enable a more complete testing approach without added complexity. |
|
|
| | |
| |
| | |
|
|
| | | | | | The 2026 MLO SOI Survey highlights trends in antimicrobial resistance testing, respiratory diagnostics, and supply chain strategies amid global economic uncertainties, emphasizing the vital role of labs in patient care and public health. |
|
|
|
| |
| | |
|
|
| | | | | | MLO invites clinical laboratory professionals to participate in a quick survey on molecular diagnostics, with results to be featured in the upcoming November issue, offering valuable industry insights. |
|
|
|
| |
| | |
|
|
| | | | | | A recent study from the University of Wisconsin–Madison and their collaborators suggests that mindfulness-based cognitive therapy (MBCT) is safe for people with recurring depression. Key findings are reported in an article by Heather Harris. |
|
|
|
| |
| | |
|
|
| | | | | | Stay connected with MLO on YouTube! Explore expert insights, laboratory management strategies, data analytics, technology, and industry perspectives—all in one place. Subscribe to @MLO-online for the latest videos from Medical Laboratory Observer. |
|
|
|
| |
| | |
|
|
| | | | | | Labcorp will offer Roche’s Elecsys pTau-217 test following clearance by the FDA, according to an announcement. The blood test aids in identifying amyloid pathology associated with Alzheimer's disease in individuals 55 and older with signs, symptoms or complaints of cognitive decline. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
